0001203311-18-000099.txt : 20181204
0001203311-18-000099.hdr.sgml : 20181204
20181204193754
ACCESSION NUMBER: 0001203311-18-000099
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181130
FILED AS OF DATE: 20181204
DATE AS OF CHANGE: 20181204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HIMES VAUGHN B
CENTRAL INDEX KEY: 0001361966
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 181218314
MAIL ADDRESS:
STREET 1: C/O SEATTLE GENETICS, INC.
STREET 2: 21823 30TH DRIVE SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2018-11-30
0
0001060736
SEATTLE GENETICS INC /WA
SGEN
0001361966
HIMES VAUGHN B
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
Chief Technical Officer
Common Stock
2018-11-30
4
S
0
4600
62.09
D
172729
D
Common Stock
2018-11-30
4
S
0
400
62.76
D
172329
D
Common Stock
2018-11-30
4
M
0
5000
12.0
A
177329
D
Non-Qualified Stock Option (right to buy)
12.0
2018-11-30
4
M
0
5000
0.0
D
2020-08-27
Common Stock
5000
36498
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Reflects sales of common stock executed in multiple transactions at prices ranging from $61.62 to $62.60. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
Reflects sales of common stock executed in multiple transactions at prices ranging from $62.64 to $62.87. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Shares vested at a rate of 25% on 8/27/11 and monthly thereafter until all the shares were fully vested on 8/27/14.
By: /s/ Jean Liu For: Vaughn B. Himes
2018-12-04